Related Experiment Video
Updated: May 28, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
[Childhood parvovirus B19 encephalitis]
P Meyer1, E Jeziorski, L Bott-Gilton
1Service d'immuno-rhumatologie et maladies infectieuses pédiatriques, université Montpellier-1, CHU de Montpellier, France. pagmeyer@yahoo.fr
Insights
Human parvovirus B19 (PVB19) can cause encephalitis in children, particularly those with febrile rash and seizures. Early diagnosis through PCR and IgM detection is crucial for effective management of this viral infection.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Virology
Background:
- Human parvovirus B19 (PVB19) is a common childhood virus causing erythema infectiosum (fifth disease).
- PVB19 infections are increasingly recognized for their association with neurological complications, including encephalitis.
Observation:
- A case report details a 3-year-old boy presenting with febrile encephalitis, characterized by altered mental status, seizures, and rash.
- Diagnostic workup included normal cerebrospinal fluid and brain imaging, with electroencephalography showing focal slowing.
Findings:
- PVB19 primo-infection was confirmed by detecting viral DNA in serum and CSF via PCR, alongside specific IgM antibodies.
- In France, PVB19 accounts for 4.3% of undiagnosed pediatric meningoencephalitis cases, often presenting with seizures and rash.
Implications:
- PVB19 should be considered in the differential diagnosis of childhood encephalitis, especially with concurrent rash and seizures.
- Testing for PVB19 is recommended in children with compatible symptoms, despite not being standard in current guidelines, due to diagnostic simplicity and efficacy.
Introduction:
Human parvovirus B19 (PVB19) causes erythema infectiosum or 5(th) disease in childhood, which mainly affects children between 3 and 15 years of age. PVB19 infections have also been described in association with a variety of neurologic manifestations including encephalitis.
Case Report:
This 3-year 8-month-old boy developed febrile encephalitis (mental status change with seizures and left limb hypertonia) associated with a rash. The electroencephalographs revealed focal slowing with some spikes in front of the left centro-temporo-occipital areas ; bacteriological and biochemical cerebrospinal fluid (CSF) analysis were normal, brain radiologic studies (tomography and magnetic resonance imaging) were normal. The diagnosis of encephalitis associated with PVB19 primo infection was based on viral DNA detection in the serum and CSF using PCR and on the specific immunoglobulin M (without immunoglobulin G) detection in the serum.
Discussion:
In France, encephalitis etiology is unknown in 48% of the cases. PVB19 accounts for 4.3% of undiagnosed meningoencephalitis in children. Although there is no specific sign, seizures and rash are reported in about one-half and one-quarter of cases, respectively.
Conclusion:
Even if PVB19 research is not cited in the French or American infectious disease society recommendations on the diagnosis and management of infectious encephalitis, this virus may be responsible, especially in cases of child febrile rash. Therefore, PVB19 research seems reasonable if the clinical presentation is concordant in children due to its diagnostic simplicity and efficacy.
Related Concept Videos
Encephalitis l: Introduction
Arboviral Encephalitis
Encephalitis ll: Pathophysiology
Poliomyelitis
Viral Meningitis
Respiratory Syncytial Virus Disease

